Abstract

BackgroundOnchocerciasis (river blindness) is a parasitic disease transmitted by blackflies. Symptoms include severe itching, skin lesions, and vision impairment including blindness. More than 99% of all cases are concentrated in sub-Saharan Africa. Fortunately, vector control and community-directed treatment with ivermectin have significantly decreased morbidity, and the treatment goal is shifting from control to elimination in Africa.MethodsWe estimated financial resources and societal opportunity costs associated with scaling up community-directed treatment with ivermectin and implementing surveillance and response systems in endemic African regions for alternative treatment goals—control, elimination, and eradication. We used a micro-costing approach that allows adjustment for time-variant resource utilization and for the heterogeneity in the demographic, epidemiological, and political situation.ResultsThe elimination and eradication scenarios, which include scaling up treatments to hypo-endemic and operationally challenging areas at the latest by 2021 and implementing intensive surveillance, would allow savings of $1.5 billion and $1.6 billion over 2013–2045 as compared to the control scenario. Although the elimination and eradication scenarios would require higher surveillance costs ($215 million and $242 million) than the control scenario ($47 million), intensive surveillance would enable treatments to be safely stopped earlier, thereby saving unnecessary costs for prolonged treatments as in the control scenario lacking such surveillance and response systems.ConclusionsThe elimination and eradication of onchocerciasis are predicted to allow substantial cost-savings in the long run. To realize cost-savings, policymakers should keep empowering community volunteers, and pharmaceutical companies would need to continue drug donation. To sustain high surveillance costs required for elimination and eradication, endemic countries would need to enhance their domestic funding capacity. Societal and political will would be critical to sustaining all of these efforts in the long term.

Highlights

  • The treatment goal for onchocerciasis has shifted from control to elimination as shown by the World Health Organization’s (WHO’s) roadmap for neglected tropical diseases (NTDs) and the London Declaration on NTDs in 2012 [1,2]

  • Vector control and community-directed treatment with ivermectin have significantly decreased morbidity, and the treatment goal is shifting from control to elimination in Africa

  • The elimination and eradication scenarios, which include scaling up treatments to hypoendemic and operationally challenging areas at the latest by 2021 and implementing intensive surveillance, would allow savings of $1.5 billion and $1.6 billion over 2013–2045 as compared to the control scenario

Read more

Summary

Introduction

The treatment goal for onchocerciasis (river blindness) has shifted from control to elimination as shown by the World Health Organization’s (WHO’s) roadmap for neglected tropical diseases (NTDs) and the London Declaration on NTDs in 2012 [1,2]. Onchocerciasis is a parasitic disease transmitted by blackflies, and notable symptoms include severe itching, skin lesions, and vision impairment including blindness. Those affected by onchocerciasis suffer negative socioeconomic consequences as a result of their symptoms [3]. In Africa, morbidity caused by onchocerciasis was significantly reduced by the vector control activities of the Onchocerciasis Control Programme (OCP) in West Africa (1975–2002) and by the community-directed treatment with ivermectin (CDTi) under the African Programme for Onchocerciasis Control (APOC) in sub-Saharan Africa and parts of West Africa (1995–present) [4]. Vector control and community-directed treatment with ivermectin have significantly decreased morbidity, and the treatment goal is shifting from control to elimination in Africa

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.